Induction of Epstein-Barr Virus Kinases To Sensitize Tumor Cells to Nucleoside Analogues

The presence of Epstein-Barr virus (EBV) in the tumor cells of some EBV-associated malignancies may facilitate selective killing of these tumor cells. We show that treatment of an EBV(+) Burkitt's lymphoma cell line with 5-azacytidine led to a dose-dependent induction of EBV lytic antigen expression...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Moore, Stacy M., Cannon, Jennifer S., Tanhehco, Yvette C., Hamzeh, Fayez M., Ambinder, Richard F.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90604/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11408227/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.7.2082-2091.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!